Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.41557 | 55 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.39429 | 56 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.39786 | 56 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.26092 | 53 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.33838 | 55 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.45338 | 55 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.41396 | 54 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.38347 | 55 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.36978 | 55 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.33441 | 54 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.36852 | 55 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.30674 | 54 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.39759 | 55 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.38786 | 55 |